Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 16
Phase 24

Trial Status

Completed13
Recruiting2

Role Distribution

Principal Investigator15
PI Rate100%

Activity Timeline

Clinical Trials (15)

NCT05436444Phase 1Completed
Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model
Influenza Infection
PrincipalinvestigatorStart date: 2023-10-23
NCT05266222Recruiting
Respiratory Virus Sampling and Repository
COVID-19Influenza
PrincipalinvestigatorStart date: 2022-08-11
NCT04609085Completed
SARS-COV2 Pandemic Serosurvey in a Rare Disease Population
SARS-COV2 Virus
PrincipalinvestigatorStart date: 2021-04-19
NCT04334954Completed
SARS-COV2 Pandemic Serosurvey and Blood Sampling
SARS-COV2 Virus
PrincipalinvestigatorStart date: 2020-08-26
NCT03641339Not ApplicableCompleted
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
ChikungunyaDengueLeishmaniasis+2 more
PrincipalinvestigatorStart date: 2018-09-05
NCT03055000Phase 1Completed
Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine
Mosquito-Borne Disease
PrincipalinvestigatorStart date: 2017-02-15
NCT01386424Recruiting
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
InfluenzaZika
PrincipalinvestigatorStart date: 2011-07-20
NCT00533182Completed
Influenza in People With Normal and Weakened Immune Systems
Respiratory InfectionsViral Infections
PrincipalinvestigatorStart date: 2008-01-03

Showing 10 of 15 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (15)

Showing 15 of 15 trials

NCT05436444Phase 1PrincipalInvestigator

Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model

Influenza Infection
Completed
NCT05266222PrincipalInvestigator

Respiratory Virus Sampling and Repository

COVID-19Influenza
Recruiting
NCT05027932Phase 1PrincipalInvestigator

Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine

Influenza
Completed
NCT04609085PrincipalInvestigator

SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

SARS-COV2 Virus
Completed
NCT04334954PrincipalInvestigator

SARS-COV2 Pandemic Serosurvey and Blood Sampling

SARS-COV2 Virus
Completed
NCT03845231Phase 2PrincipalInvestigator

Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular Route

Influenza
Completed
NCT03641339Not ApplicablePrincipalInvestigator

Defining Skin Immunity of a Bite of Key Insect Vectors in Humans

ChikungunyaDengueLeishmaniasis+2 more
Completed
NCT03055000Phase 1PrincipalInvestigator

Safety and Immunogenicity of a First-in-Human Mosquito Saliva Peptide Vaccine

Mosquito-Borne Disease
Completed
NCT01386424PrincipalInvestigator

Screening for LID Clinical Studies Unit Healthy Volunteer Protocols

InfluenzaZika
Recruiting
NCT00533182PrincipalInvestigator

Influenza in People With Normal and Weakened Immune Systems

Respiratory InfectionsViral Infections
Completed
NCT01646138Phase 1/2PrincipalInvestigator

Influenza A 2009 H1N1 Challenge Study in Healthy Adults

Influenza
Completed
NCT01971255Phase 1/2PrincipalInvestigator

Evaluation of Anti-Hemagglutinin (Anti-HA) Antibodies as Protection From the Flu in Healthy People

Influenza
Completed
NCT02124096PrincipalInvestigator

Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs

Influenza
Completed
NCT02371668Phase 2PrincipalInvestigator

Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model

H1N1 Influenza Healthy Volunteers
Completed
NCT02594189Phase 1PrincipalInvestigator

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2
Completed

All 15 trials loaded